Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Marinus Pharmaceuticals Inc shares valued at $20,583 were sold by Shafer Christina on Feb 20 ’24. At $9.56 per share, Shafer Christina sold 2,153 shares. The insider’s holdings dropped to 60,308 shares worth approximately $0.49 million following the completion of this transaction.
Also, MANNING MARTHA E sold 1,894 shares, netting a total of over 18,126 in proceeds. Following the sale of shares at $9.57 each, the insider now holds 52,966 shares.
Before that, Braunstein Scott had sold 11,850 shares from its account. In a trade valued at $117,789, the CHAIRMAN AND CEO traded Marinus Pharmaceuticals Inc shares for $9.94 each. Upon closing the transaction, the insider’s holdings decreased to 11,850 shares, worth approximately $1.81 million.
As published in a research note from Oppenheimer on August 11, 2023, Marinus Pharmaceuticals Inc [MRNS] has been rated down from an Outperform to a Perform and the price target has been revised to $9 from $14. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid January. As of September 30, 2020, Truist has initiated its “Buy” rating for MRNS. Earlier on July 01, 2020, H.C. Wainwright resumed its rating. Their recommendation was “a Buy” for MRNS stock.
Analyzing MRNS Stock Performance
During the last five days, there has been a drop of approximately -7.01%. Over the course of the year, Marinus Pharmaceuticals Inc shares have dropped approximately -25.57%. Shares of the company reached a 52-week high of $11.26 on 01/08/24 and a 52-week low of $7.42 on 04/08/24. A 50-day SMA is recorded $9.34, while a 200-day SMA reached $8.55. Nevertheless, trading volume fell to 0.67 million shares from 0.69 million shares the previous day.
Support And Resistance Levels for Marinus Pharmaceuticals Inc (MRNS)
According to the 24-hour chart, there is a support level at 7.89, which, if violated, would cause prices to drop to 7.68. In the upper region, resistance lies at 8.29. The next price resistance is at 8.48. RSI (Relative Strength Index) is 38.24 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.43, which suggests the price will decrease in the coming days. Percent R is at 66.33%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Marinus Pharmaceuticals Inc subject to short interest?
Stocks of Marinus Pharmaceuticals Inc saw a sharp rise in short interest on Mar 15, 2024 jumping by 0.0 shares to 3.57 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 3.57 million shares.
